Oracle is teaming up with the University of Tokyo to research the emerging field of tailor-made medical care, which takes into account a patient's genetic traits, such as race, to treat illness and disease. Oracle's Japanese subsidiary has agreed to help fund the project as well as contribute database software and data-analysis expertise, the company said this month. The company did not immediately quantify the value of its contributions.
Biotechnology has fascinated Oracle Chief Executive Larry Ellison for years. The billionaire software tycoon has funded several biotech ventures and donated to numerous medical causes. The Ellison Medical Foundation, a nonprofit he established in 1997, supports research on aging and age-related diseases.
Join the conversation
Comment replyThe posting of advertisements, profanity, or personal attacks is prohibited. Click here to review our Terms of Use.
Google creates an animated doodle that features a boy, a girl, Google's search engine, and a jump rope. But might there be darker, more analytical, more troubling interpretations to this tale?
The Silicon Valley online payments startup grew by 1,000 percent last year and is hopeful it can repeat that level of growth this year. To do that, it's had to move away from its early friends-and-family roots and embrace small businesses.
Chamtech's spray-on antenna uses a nano material to provide a low-power boost to antenna range. The wireless-in-a-can product may some day bring an end to unsightly cell towers.
EnerG2 opens a plant to make an engineered carbon that will improve performance of energy storage devices and make storage for start-stop hybrid cars less expensive.
Join the conversation